Jay Nath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jay Nath has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Adnan Sharif
Department of Nephrology and Transplantation Queen Elizabeth Hospital Birmingham UK
4 shared publications- Christian Ludwig
Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, United Kingdom
4 shared publications - James Hodson
Health Data Research, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK
4 shared publications Adam Arshad
Medical School University of Birmingham Birmingham United Kingdom
3 shared publications- Adnan Sharif
Department of Nephrology and Transplantation, University Hospital Birmingham, Birmingham, UK.
3 shared publications Andrew R. Ready
Department of Renal Surgery, University Hospitals Birmingham, Birmingham, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 10 December 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (1) , e1736
Metabolic Characterization of Deceased Donor Kidneys Undergoing Hypothermic Machine Perfusion Before Transplantation Using 13C-enriched Glucose
Background.: The provision of a metabolic substrate is one mechanism by which hypothermic machine perfusion (HMP) of kidneys provides clinical benefit. This study aimed to describe de novo metabolism in ex vivo human kidneys undergoing HMP before transplantation using 13C-labeled glucose as a metabolic tracer. Methods.: Cadaveric human kidneys were perfused with modified clinical-grade perfusion fluid (kidney perfusion solution [KPS-1], Organ Recovery Systems), in which glucose was uniformly enriched with the stable isotope 13C ([U-13C] glucose). The sampled perfusion fluid was analyzed using a blood gas analyzer, and metabolic profiling was performed using 1-dimensional and 2-dimensional nuclear magnetic resonance spectroscopy and mass spectrometry. Functional outcome measures included serum creatinine levels and the development of delayed graft function. Results.: Fourteen kidneys were perfused with the modified KPS-1 and successfully transplanted. The mean duration of HMP was 8.7 h. There was a sustained increase in the conversion of glucose into de novo glycolytic end products, such as lactate, in donor kidneys during HMP. There was no significant association between functional outcomes and metabolism during the HMP. De novo anaerobic metabolism was indicated by continuing lactate production, as indicated by increasing concentrations of universally 13C-labeled lactate ([U-13C] lactate) in perfusion fluid from all kidneys. This was more evident in donation after circulatory death donor kidneys. Conclusions.: Our study is the first to use [U-13C] glucose to describe the metabolism during HMP. The consequences of an initial warm ischemic insult on circulatory death in donor kidneys continue during the preservation period.
- 10 December 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (1) , e1736
Open AccessMetabolic Characterization of Deceased Donor Kidneys Undergoing Hypothermic Machine Perfusion Before Transplantation Using 13C-enriched Glucose
Background.: The provision of a metabolic substrate is one mechanism by which hypothermic machine perfusion (HMP) of kidneys provides clinical benefit. This study aimed to describe de novo metabolism in ex vivo human kidneys undergoing HMP before transplantation using 13C-labeled glucose as a metabolic tracer. Methods.: Cadaveric human kidneys were perfused with modified clinical-grade perfusion fluid (kidney perfusion solution [KPS-1], Organ Recovery Systems), in which glucose was uniformly enriched with the stable isotope 13C ([U-13C] glucose). The sampled perfusion fluid was analyzed using a blood gas analyzer, and metabolic profiling was performed using 1-dimensional and 2-dimensional nuclear magnetic resonance spectroscopy and mass spectrometry. Functional outcome measures included serum creatinine levels and the development of delayed graft function. Results.: Fourteen kidneys were perfused with the modified KPS-1 and successfully transplanted. The mean duration of HMP was 8.7 h. There was a sustained increase in the conversion of glucose into de novo glycolytic end products, such as lactate, in donor kidneys during HMP. There was no significant association between functional outcomes and metabolism during the HMP. De novo anaerobic metabolism was indicated by continuing lactate production, as indicated by increasing concentrations of universally 13C-labeled lactate ([U-13C] lactate) in perfusion fluid from all kidneys. This was more evident in donation after circulatory death donor kidneys. Conclusions.: Our study is the first to use [U-13C] glucose to describe the metabolism during HMP. The consequences of an initial warm ischemic insult on circulatory death in donor kidneys continue during the preservation period.
- Open Access
- 19 July 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (12) , 4095-4097
Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia
- 19 July 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (12) , 4095-4097
Open AccessOrgan transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia
- 27 February 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (5) , e14272
Macroscopic assessment of the quality of cold perfusion after deceased‐donor kidney procurement: A United Kingdom population‐based cohort study
Concern regarding the quality of cold perfusion (QOP) during macroscopic assessment of procured kidneys is a common reason for discard. In the UK, QOP is routinely graded by both retrieving and implanting teams during back‐bench surgery as: 1 (good), 2 (fair), 3 (poor) or 4 (patchy). We evaluated the association of this grading with organ utilization, graft outcomes, and agreement between teams. Data on all deceased‐donor kidneys procured between January 2000 and December 2016 were analyzed for discard rates, while association with graft outcomes was studied in single adult transplants. Of 31,167 kidneys procured, 90.6%, 5.7%, 1.7%, and 2.1% were assigned grades 1, 2, 3, and 4, respectively, at retrieval. QOP was an independent risk factor of discard, with the highest rates observed in grade 3 kidneys (41.8%), compared to 6.5% in grade 1 (aOR 7.67, 95% CI 5.44–10.82, p < .001). Grading at retrieval was an independent predictor of delayed graft function (p = .019) and primary non‐function (p = .001), but not long‐term graft survival (p = .111). Implanting grade was an independent predictor of all three outcomes (p < .001, p < .001, and p = .002, respectively). Consistency of grading between teams was poor (Kappa = 0.179). QOP influences utilization and predicts outcomes, but a standardized and validated scoring system is required.
- 27 February 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (5) , e14272
Macroscopic assessment of the quality of cold perfusion after deceased‐donor kidney procurement: A United Kingdom population‐based cohort study
Concern regarding the quality of cold perfusion (QOP) during macroscopic assessment of procured kidneys is a common reason for discard. In the UK, QOP is routinely graded by both retrieving and implanting teams during back‐bench surgery as: 1 (good), 2 (fair), 3 (poor) or 4 (patchy). We evaluated the association of this grading with organ utilization, graft outcomes, and agreement between teams. Data on all deceased‐donor kidneys procured between January 2000 and December 2016 were analyzed for discard rates, while association with graft outcomes was studied in single adult transplants. Of 31,167 kidneys procured, 90.6%, 5.7%, 1.7%, and 2.1% were assigned grades 1, 2, 3, and 4, respectively, at retrieval. QOP was an independent risk factor of discard, with the highest rates observed in grade 3 kidneys (41.8%), compared to 6.5% in grade 1 (aOR 7.67, 95% CI 5.44–10.82, p < .001). Grading at retrieval was an independent predictor of delayed graft function (p = .019) and primary non‐function (p = .001), but not long‐term graft survival (p = .111). Implanting grade was an independent predictor of all three outcomes (p < .001, p < .001, and p = .002, respectively). Consistency of grading between teams was poor (Kappa = 0.179). QOP influences utilization and predicts outcomes, but a standardized and validated scoring system is required.
- Open Access
ShearFAST: a user-friendly in vitro toolset for high throughput, inexpensive fluid shear stress experiments
Fluid shear stress is a key modulator of cellular physiology in vitro and in vivo , but its effects are under-investigated due to requirements for complicated induction methods. Herein we report the validation of ShearFAST; a smartphone application that measures the rocking profile on a standard laboratory cell rocker and calculates the resulting shear stress arising in tissue culture plates. ShearFAST measured rocking profiles were validated against a graphical analysis and also against measures reported by an 8-camera motion tracking system. ShearFAST angle assessments correlated well with both analyses (r ≥0.99, p ≤0.001) with no significant differences in pitch detected across the range of rocking angles tested. Rocking frequency assessment by ShearFAST also correlated well when compared to the two independent validatory techniques (r ≥0.99, p ≤0.0001), with excellent reproducibility between ShearFAST and video analysis (mean frequency measurement difference of 0.006 ± 0.005Hz) and motion capture analysis (mean frequency measurement difference of 0.008 ± 0.012Hz) These data make the ShearFAST assisted cell rocker model make it an attractive approach for economical, high throughput fluid shear stress experiments. Abstract Figure:
Open AccessShearFAST: a user-friendly in vitro toolset for high throughput, inexpensive fluid shear stress experiments
Fluid shear stress is a key modulator of cellular physiology in vitro and in vivo , but its effects are under-investigated due to requirements for complicated induction methods. Herein we report the validation of ShearFAST; a smartphone application that measures the rocking profile on a standard laboratory cell rocker and calculates the resulting shear stress arising in tissue culture plates. ShearFAST measured rocking profiles were validated against a graphical analysis and also against measures reported by an 8-camera motion tracking system. ShearFAST angle assessments correlated well with both analyses (r ≥0.99, p ≤0.001) with no significant differences in pitch detected across the range of rocking angles tested. Rocking frequency assessment by ShearFAST also correlated well when compared to the two independent validatory techniques (r ≥0.99, p ≤0.0001), with excellent reproducibility between ShearFAST and video analysis (mean frequency measurement difference of 0.006 ± 0.005Hz) and motion capture analysis (mean frequency measurement difference of 0.008 ± 0.012Hz) These data make the ShearFAST assisted cell rocker model make it an attractive approach for economical, high throughput fluid shear stress experiments. Abstract Figure:
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i296-i297
FP744DIFFERENCE IN BASELINE DEMOGRAPHICS AND OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS REFERRED INTERNALLY OR EXTERNALLY TO TRANSPLANT CENTRE FOR SURGERY
INTRODUCTION AND AIMS: Many end-stage kidney disease patients referred for kidney transplantation are under the care of nephrology teams external to transplant centres. However, the following issues are unclear; 1) whether characteristics differ between internal or external transplant referrals, and 2) whether post-transplant outcomes differ dependent upon whether patients are internally or externally referred.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i296-i297
FP744DIFFERENCE IN BASELINE DEMOGRAPHICS AND OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS REFERRED INTERNALLY OR EXTERNALLY TO TRANSPLANT CENTRE FOR SURGERY
INTRODUCTION AND AIMS: Many end-stage kidney disease patients referred for kidney transplantation are under the care of nephrology teams external to transplant centres. However, the following issues are unclear; 1) whether characteristics differ between internal or external transplant referrals, and 2) whether post-transplant outcomes differ dependent upon whether patients are internally or externally referred.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i284
FP708CLINIC NON-ATTENDANCE WITHIN THE FIRST YEAR POST KIDNEY TRANSPLANTATION IS ASSOCIATED WITH REJECTION, GRAFT DYSFUNCTION AND DEATH-CENSORED GRAFT LOSS
INTRODUCTION AND AIMS: Non-attendance to transplant clinic follow up is intuitively associated with poor outcomes for kidney transplant recipients but there is little objective evidence in the transplant literature to that effect. The aim of this study was to analyse the impact of clinic non-attendance on post-transplantation outcomes.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i284
FP708CLINIC NON-ATTENDANCE WITHIN THE FIRST YEAR POST KIDNEY TRANSPLANTATION IS ASSOCIATED WITH REJECTION, GRAFT DYSFUNCTION AND DEATH-CENSORED GRAFT LOSS
INTRODUCTION AND AIMS: Non-attendance to transplant clinic follow up is intuitively associated with poor outcomes for kidney transplant recipients but there is little objective evidence in the transplant literature to that effect. The aim of this study was to analyse the impact of clinic non-attendance on post-transplantation outcomes.
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3)
SP728NON-WHITE DONORS AND KIDNEY TRANSPLANT OUTCOMES: A POPULATION COHORT STUDY
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3)
SP728NON-WHITE DONORS AND KIDNEY TRANSPLANT OUTCOMES: A POPULATION COHORT STUDY
- Open Access
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii740
MP831ANALYSIS OF A NATIONAL DATASET: SINGLE KIDNEY TRANSPLANT OUTCOMES IN PAEDIATRIC DONORS TO ADULT RECIPIENTS
INTRODUCTION AND AIMS: The disparity between supply and demand for organs in kidney transplantation has forced a re-evaluation of the limits on donor age acceptability. Single organ paediatric donor kidneys are underutilized at some centres, but it is unclear whether they have inferior outcomes for adult recipients. The aim of this nationwide population-cohort analysis was to look at the outcomes of paediatric donors in adult recipients.
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii740
Open AccessMP831ANALYSIS OF A NATIONAL DATASET: SINGLE KIDNEY TRANSPLANT OUTCOMES IN PAEDIATRIC DONORS TO ADULT RECIPIENTS
INTRODUCTION AND AIMS: The disparity between supply and demand for organs in kidney transplantation has forced a re-evaluation of the limits on donor age acceptability. Single organ paediatric donor kidneys are underutilized at some centres, but it is unclear whether they have inferior outcomes for adult recipients. The aim of this nationwide population-cohort analysis was to look at the outcomes of paediatric donors in adult recipients.
- Open Access
- 30 January 2017
- Published by Wiley in Cancer Medicine
- Vol. 6 (3) , 563-571
Cancer‐related outcomes in kidney allograft recipients in England versus New York State: a comparative population‐cohort analysis between 2003 and 2013
It is unclear whether cancer‐related epidemiology after kidney transplantation is translatable between countries. In this population‐cohort study, we compared cancer incidence and all‐cause mortality after extracting data for every kidney‐alone transplant procedure performed in England and New York State (NYS) between 2003 and 2013. Data were analyzed for 18,493 and 11,602 adult recipients from England and NYS respectively, with median follow up 6.3 years and 5.5 years respectively (up to December 2014). English patients were more likely to have previous cancer at time of transplantation compared to NYS patients (5.6% vs. 3.5%, P < 0.001). Kidney allograft recipients in England versus NYS had increased cancer incidence (12.3% vs. 5.9%, P < 0.001) but lower all‐cause mortality during the immediate postoperative stay (0.7% vs. 1.0%, P = 0.011), after 30‐days (0.9% vs. 1.8%, P < 0.001) and after 1‐year post‐transplantation (3.0% vs. 5.1%, P < 0.001). However, mortality rates among patients developing post‐transplant cancer were equivalent between the two countries. During the first year of follow up, if patients had an admission with a cancer diagnosis, they were more likely to die in both England (Odds Ratio 4.28 [95% CI: 3.09–5.93], P < 0.001) and NYS (Odds Ratio 2.88 [95% CI: 1.70–4.89], P < 0.001). Kidney allograft recipients in NYS demonstrated higher hazard ratios for developing kidney transplant rejection/failure compared to England on Cox regression analysis. Our analysis demonstrates significant differences in cancer‐related epidemiology between kidney allograft recipients in England versus NYS, suggesting caution in translating post‐transplant cancer epidemiology between countries.
- 30 January 2017
- Published by Wiley in Cancer Medicine
- Vol. 6 (3) , 563-571
Open AccessCancer‐related outcomes in kidney allograft recipients in England versus New York State: a comparative population‐cohort analysis between 2003 and 2013
It is unclear whether cancer‐related epidemiology after kidney transplantation is translatable between countries. In this population‐cohort study, we compared cancer incidence and all‐cause mortality after extracting data for every kidney‐alone transplant procedure performed in England and New York State (NYS) between 2003 and 2013. Data were analyzed for 18,493 and 11,602 adult recipients from England and NYS respectively, with median follow up 6.3 years and 5.5 years respectively (up to December 2014). English patients were more likely to have previous cancer at time of transplantation compared to NYS patients (5.6% vs. 3.5%, P < 0.001). Kidney allograft recipients in England versus NYS had increased cancer incidence (12.3% vs. 5.9%, P < 0.001) but lower all‐cause mortality during the immediate postoperative stay (0.7% vs. 1.0%, P = 0.011), after 30‐days (0.9% vs. 1.8%, P < 0.001) and after 1‐year post‐transplantation (3.0% vs. 5.1%, P < 0.001). However, mortality rates among patients developing post‐transplant cancer were equivalent between the two countries. During the first year of follow up, if patients had an admission with a cancer diagnosis, they were more likely to die in both England (Odds Ratio 4.28 [95% CI: 3.09–5.93], P < 0.001) and NYS (Odds Ratio 2.88 [95% CI: 1.70–4.89], P < 0.001). Kidney allograft recipients in NYS demonstrated higher hazard ratios for developing kidney transplant rejection/failure compared to England on Cox regression analysis. Our analysis demonstrates significant differences in cancer‐related epidemiology between kidney allograft recipients in England versus NYS, suggesting caution in translating post‐transplant cancer epidemiology between countries.